Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
QuintilesIMS
Moodys
Chubb
Cerilliant
Argus Health
Teva
US Department of Justice
Chinese Patent Office

Generated: October 21, 2017

DrugPatentWatch Database Preview

Organon Usa Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ORGANON USA INC, and what generic alternatives to ORGANON USA INC drugs are available?

ORGANON USA INC has thirty-four approved drugs.

There are eight US patents protecting ORGANON USA INC drugs. There is one tentative approval on ORGANON USA INC drugs.

There are one hundred and seventy-nine patent family members on ORGANON USA INC drugs in forty countries and thirty-three supplementary protection certificates in eleven countries.

Summary for Applicant: Organon Usa Inc

International Patents:179
US Patents:8
Tradenames:34
Ingredients:29
NDAs:34
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc
FOLLISTIM
follitropin alfa/beta
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS020582-002Sep 29, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
RAPLON
rapacuronium bromide
INJECTABLE;INJECTION020984-002Aug 18, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
HEXADROL
dexamethasone sodium phosphate
INJECTABLE;INJECTION014694-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
DURABOLIN
nandrolone phenpropionate
INJECTABLE;INJECTION011891-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
MAXIBOLIN
ethylestrenol
ELIXIR;ORAL014006-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
HUMEGON
menotropins (fsh;lh)
INJECTABLE;INJECTION020328-002Sep 1, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
NORCURON
vecuronium bromide
INJECTABLE;INJECTION018776-003Jan 3, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
MAXIBOLIN
ethylestrenol
TABLET;ORAL014005-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
FOLLISTIM AQ
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021273-002Aug 26, 2005DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Organon Usa Inc
LIQUAEMIN SODIUM
heparin sodium
INJECTABLE;INJECTION000552-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Organon Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc
GANIRELIX ACETATE
ganirelix acetate
INJECTABLE;INJECTION021057-001Jul 29, 1999► Subscribe► Subscribe
Organon Usa Inc
REMERON
mirtazapine
TABLET;ORAL020415-003Mar 17, 1997► Subscribe► Subscribe
Organon Usa Inc
REMERON SOLTAB
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL021208-003Jan 12, 2001► Subscribe► Subscribe
Organon Usa Inc
RAPLON
rapacuronium bromide
INJECTABLE;INJECTION020984-001Aug 18, 1999► Subscribe► Subscribe
Organon Usa Inc
GANIRELIX ACETATE
ganirelix acetate
INJECTABLE;INJECTION021057-001Jul 29, 1999► Subscribe► Subscribe
Organon Usa Inc
FOLLISTIM AQ
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021211-001Mar 23, 2004► Subscribe► Subscribe
Organon Usa Inc
FOLLISTIM
follitropin alfa/beta
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS020582-002Sep 29, 1997► Subscribe► Subscribe
Organon Usa Inc
REMERON SOLTAB
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL021208-001Jan 12, 2001► Subscribe► Subscribe
Organon Usa Inc
FOLLISTIM
follitropin alfa/beta
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS020582-001Sep 29, 1997► Subscribe► Subscribe
Organon Usa Inc
FOLLISTIM
follitropin alfa/beta
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS020582-001Sep 29, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ORGANON USA INC drugs

Drugname Dosage Strength Tradename Submissiondate
ethinyl estradiol and etonogestrel
Vaginal Ring0.015 mg/24 hour and 0.12 mg/24 hour
NUVARING
6/17/2013
ganirelix acetate
Injection250 mcg/0.5 mL, 1 mL PFS
GANIRELIX ACETATE
3/30/2012

International Patent Family for Organon Usa Inc Drugs

Country Document Number Estimated Expiration
Peru09392000► Subscribe
Singapore65061► Subscribe
Taiwan358031► Subscribe
Canada2593848► Subscribe
Malaysia135913► Subscribe
Argentina056923► Subscribe
Australia5205998► Subscribe
South Korea20070027530► Subscribe
Ukraine89518► Subscribe
South Korea20070112144► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Organon Usa Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00C/030Belgium► SubscribePRODUCT NAME: GANIRELIX; REGISTRATION NO/DATE: EU/1/00/130/001 20000518
C/GB00/024United Kingdom► SubscribePRODUCT NAME: GANIRELIX OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/130/001 20000517; UK EU/1/00/130/002 20000517
C0012France► SubscribePRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
655Luxembourg► Subscribe91655, EXPIRES: 20230113
0814Netherlands► SubscribePRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
C0038Belgium► SubscribePRODUCT NAME: ROCURONIUMBROMIDE; NAT. REGISTRATION NO/DATE: 63 IS 9 F 12 19960709; FIRST REGISTRATION: NL RVG 16946 19940406
C019/2010Ireland► SubscribeSPC019/2010: 20101001, EXPIRES: 20230112
2016 00016Denmark► SubscribePRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
/2015Austria► SubscribePRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
6/2010Austria► SubscribePRODUCT NAME: CORIFOLLITROPIN ALFA
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Healthtrust
Merck
Fuji
Moodys
McKesson
Novartis
Farmers Insurance
QuintilesIMS
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot